Distinct Proteomic and Glycosylation Signatures Differentiate A549 Tumor and BEAS-2B Nontumor Cell Line–Derived Small Extracellular Vesicles
Molecular & Cellular Proteomics · 2026
DOI: 10.1016/j.mcpro.2026.101524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2026. Verfasst von Mirjam Balbisi und 15 weiteren Autor:innen. Beteiligte Einrichtung: MTA-HUN-REN TTK Lendület (Momentum) Glycan Biomarker Research Group, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary; Doctoral School…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Proteomics, Lung Neoplasms, Proteome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EMBO, Dutch Research Council, Hungarian Academy of Sciences.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are central to intercellular communication and have gained attention as rich sources of molecular information in cancer research, but their molecular composition remains incompletely characterized. Protein glycosylation is a frequent post-translational modification; however, most EV studies focus on proteomics, whereas mapping glycosylation changes of proteins is still under-represented. To address this gap, we analyzed the proteomic, N-glycoproteomic, and chondroitin sulfate/dermatan sulfate (CS/DS) glycosaminoglycan (GAG) profiles of small EVs (sEVs) derived from A549 lung adenocarcinoma and BEAS-2B nontumorigenic epithelial cells. Principal component analysis and hierarchical clustering revealed that all three profiles strongly reflect sEV origin. Comparative proteomic analysis showed enrichment of proteins associated with cell cycle regulation, DNA repair, metabolism, and protein synthesis in A549 sEVs, whereas immune-related processes were enriched in BEAS-2B sEVs. Five differentially expressed CS proteoglycans were identified, highlighting the value of complementary GAG-level analysis. N-glycoproteomics revealed a shift from oligomannose to complex N-glycans in A549 sEVs. Prominent glycoproteins with multiple glycosylation sites included versican, galectin-3-binding protein, and laminins. CS/DS content increased 3.4-fold in A549 sEVs, whereas the ratio of the two monosulfated disaccharides changed twofold. These findings demonstrate the utility of N-glycoproteomics and GAG profiling for sensitively characterizing molecular differences between sEVs derived from different cell culture models, thereby providing a foundation for future EV biomarker studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MTA-HUN-REN TTK Lendület (Momentum) Glycan Biomarker Research Group, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary; Doctoral School, Semmelweis University, Budapest, Hungary.
- Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.
- MTA-HUN-REN TTK Lendület (Momentum) Glycan Biomarker Research Group, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.
- MTA-ELTE Lendület (Momentum) Ion Mobility Mass Spectrometry Research Group, ELTE Eötvös Loránd University, Institute of Chemistry, Budapest, Hungary.
- Department of Medical Chemistry, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
- Biological Nanochemistry Research Group, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary; Hevesy György PhD School of Chemistry, ELTE Eötvös Loránd University, Budapest, Hungary.
Förderung
- EMBO
- Dutch Research Council
- Hungarian Academy of Sciences
- National Research Development and Innovation Office
- Innovációs és Technológiai Minisztérium
- Nemzeti Kutatási, Fejlesztési és Innovaciós Alap
- European Molecular Biology Organization
- International Centre for Genetic Engineering and Biotechnology
Zitieren
APA
Balbisi, M., Langó, T., Horváth, V. N., Pál, D., Schlosser, G., Kecskeméti, G., Szabó, Z., Ilyés, K., Nagy, N., Tóth, O., Zheng, J., Lageveen-Kammeijer, G. S. M., Visnovitz, T., Varga, Z., G Vértessy, B., & Turiák, L. (2026). Distinct Proteomic and Glycosylation Signatures Differentiate A549 Tumor and BEAS-2B Nontumor Cell Line–Derived Small Extracellular Vesicles. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2026.101524
Vancouver
Balbisi M, Langó T, Horváth VN, Pál D, Schlosser G, Kecskeméti G, et al. Distinct Proteomic and Glycosylation Signatures Differentiate A549 Tumor and BEAS-2B Nontumor Cell Line–Derived Small Extracellular Vesicles. Molecular & Cellular Proteomics. 2026. doi:10.1016/j.mcpro.2026.101524
BibTeX
@article{Balbisi2026,
author = {Balbisi, Mirjam and Langó, Tamás and Horváth, Virág Nikolett and Pál, Domonkos and Schlosser, Gitta and Kecskeméti, Gábor and Szabó, Zoltán and Ilyés, Kinga and Nagy, Nikolett and Tóth, Otília and Zheng, Jing and Lageveen-Kammeijer, Guinevere S M and Visnovitz, Tamás and Varga, Zoltán and G Vértessy, Beáta and Turiák, Lilla},
title = {Distinct Proteomic and Glycosylation Signatures Differentiate A549 Tumor and BEAS-2B Nontumor Cell Line–Derived Small Extracellular Vesicles},
journal = {Molecular & Cellular Proteomics},
year = {2026},
doi = {10.1016/j.mcpro.2026.101524}
}
EUVIMED